Follicular Lymphoma
Reduced Intensity Salvage Allo-HCT Effective for Follicular Lymphoma
March 09, 2016Reduced intensity allogeneic hematopoietic cell transplantation (HCT) is an effective salvage treatment strategy in patients with follicular lymphoma.
Study Identifies Factors Influencing Advanced Follicular Lymphoma Outcomes
January 22, 2016Induction therapy with lenalidomide plus rituximab may result in control that is comparable to rituximab plus chemotherapy for the initial treatment.
Early relapse of follicular lymphoma may increase risk of death
July 02, 2015Early relapse of follicular lymphoma could be carefully considered when making decisions about treatment for these patients.
Managing follicular lymphoma
July 17, 2014Changes in how follicular lymphoma is managed have led to substantial improvement in prognosis and over all survival for patients with the disease.
New treatment regimens improving outcomes for follicular lymphoma
September 19, 2013Vaccines and monoclonal antibodies are promising new treatments for patients with follicular lymphoma.
Watchful waiting strategy OK in low-tumor burden follicular lymphoma
September 26, 2012Compared with rituximab, an initial watch-and-wait strategy is not detrimental in select patients.
Stem cell treatment does not improve overall survival in follicular lymphoma
January 12, 2012High-dose chemotherapy combined with autologous stem cell transplantation did not improve overall survival in previously untreated adult patients with follicular lymphoma.
Sign Up for Free e-newsletters
ONA Articles
- Redefining Prognosis for Hematologic Cancers in Older Adults by Age
- Progression-Free Survival Extended With PANEX Protocol in R/R Multiple Myeloma
- In Older Women With Breast Cancer QoL May Predict 10-Year Mortality
- Evolving Role of Radiation Therapy in the Treatment of Mesothelioma
- Elderly Patients Are Underrepresented in Trials For Soft Tissue Sarcoma
- Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family
- Pivot Nurse Improves Patients' Navigation Through Lung Cancer Care
- Long-term Carfilzomib May Be Safe, Effective In Relapsed Multiple Myeloma
- Palliative Sedation a Valid Option for Refractory Symptoms in End-stage Cancer
- Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases
- False-Positive Cancer Screening Results May Increase Likelihood of Future Screenings
- Lenalidomide Alone or With Dexamethasone Effective in Relapsed Multiple Myeloma
- Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases
- Spotlight on Triptorelin in the Treatment of Premenopausal Women with Early-Stage Breast Cancer
- Redefining Prognosis for Hematologic Cancers in Older Adults by Age
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |